tracken
Exact Sciences Corporation Aktie News
Neutral
Business Wire
●
etwa 2 Monate alt
ROCHESTER, Minn. & MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences and Mayo Clinic advance precision cancer medicine by bringing comprehensive genomic profiling and hereditary cancer tests to patients.
Positiv
Investors Business Daily
●
etwa 2 Monate alt
Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.
Neutral
Business Wire
●
2 Monate alt
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Comprehensive Cancer Center, reported on data showing high sensitivity and specificity for the non-endoscopic Oncoguard® Esophagus test that is currently in development for the detection of esophageal adenocarcinoma (EAC) and its pre...
Neutral
Business Wire
●
2 Monate alt
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has received the 2024 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged workplace cultures in the world. Gallup created the Exceptional Workplace Award to identify excellence and celebrate organizations that incorpor...
Positiv
InvestorPlace
●
2 Monate alt
Identifying growth stocks to buy at this time, especially at their 52-week lows, can be challenging. With the market trending upward, current optimism suggests fewer stocks near their lows.
Neutral
Business Wire
●
2 Monate alt
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, "Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening", will also appear in the journal's March 14, 2024 print issue....
Positiv
Investors Business Daily
●
2 Monate alt
Exact Sciences stock could jump after the company said Wednesday that its next-generation Cologuard beat a rival stool-based screening test.
Positiv
The Motley Fool
●
3 Monate alt
Exact Sciences' key product and its efforts to keep expenses down bode well for its future. Block's addressable market is massively underpenetrated, especially outside the U.S.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
